Precision BioSciences, Inc.

Historical 13F Holders

Symbol
DTIL
CUSIP
74019P207
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 74019P207 since 12/18/2024, largest first.

Filer % of Class Filed
Octagon Capital Advisors LP 13G
10.0% 2/10/2026
Event 12/31/2025
Readout Capital, LP 13G/A
9.4% 8/14/2025
Event 6/30/2025
Aberdeen Group plc 13G
8.9% 1/27/2026
Event 12/31/2025
Bleichroeder LP 13G/A
8.2% 2/13/2026
Event 12/31/2025
Lynx1 Capital Management LP 13G
5.4% 7/20/2026
Event 7/13/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Empery Asset Management, LP 13G/A
4.99% 7/29/2026
Event 6/30/2026
Weinstein Benjamin 13G/A 4.0% 8/24/2026
Event 8/21/2026
Novartis Pharma AG 13G/A
3.7% 8/6/2025
Event 6/30/2025
Highbridge Capital Management, LLC 13G/A 3.7% 4/25/2025
Event 3/31/2025
Aquilo Capital Management, LLC 13G/A
0% 8/6/2025
Event 6/30/2025
Janus Henderson Group PLC 13G/A 0% 2/14/2025
Event 12/31/2024
Tang Capital Management LLC 13G/A
0% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 278 $1.74 k
2026 Q2 98 17.7 M $139 M
2026 Q1 79 16.2 M $88.1 M
2025 Q4 70 15.1 M $62.8 M
2025 Q3 57 4.65 M $25.7 M
2025 Q2 54 4.48 M $18.8 M
2025 Q1 49 3.79 M $18.1 M
2024 Q4 56 3.88 M $14.7 M
2024 Q3 53 3.32 M $29.8 M
2024 Q2 50 3.17 M $30.9 M
2024 Q1 47 3.20 M $43.3 M